Morepen Laboratories Ltd (NSE:MOREPENLAB) Share Price

Company Profile

Business description
Morepen Laboratories Ltd is in the business of manufacturing, producing, developing, and marketing various Active Pharmaceutical Ingredients (APIs), branded and generic formulations, and also Home Health products. Some of the products offered by the company include various drug formulations, APIs, digital thermometers, heat belts, pulse oximeters, nutritional tablets, pain sprays, and others. The company operates in a single segment namely, Pharmaceuticals. Geographically, the company derives maximum revenue from India and the rest from the United States of America, and the Rest of the world.
Contact
Udyog Vihar-III, Sector-20
2nd Floor, Tower C, DLF Cyber Park
GurugramHR122016
IND
T: +91 1244892000
https://www.morepen.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2025
Employees
2,599

Recommended

Morningstar's Chief Investment Officer for Asia-Pacific and Director of Personal Finance share their thoughts on the recent RBA rate cut.

Matt Wacher | 21 February 2025

We’ve upgraded our fair value estimate for 29 companies, or 40% of those that have reported thus far.

Lochlan Halloway | 20 February 2025

Our analysts think these companies are undervalued and their shares appear to have the stamp of approval from highly rated managers.

Joseph Taylor | 20 February 2025

Index	Last price	Change	% Change
All Ordinaries	8,570.90	30.80	-0.36%
CAC 40	8,154.51	31.93	0.39%
DAX 40	22,287.56	27.09	-0.12%
Dow JONES (US)	43,725.89	450.76	-1.02%
FTSE 100	8,659.37	3.60	-0.04%
HKSE	23,477.92	900.94	3.99%
NASDAQ	19,764.02	198.34	-0.99%
Nikkei 225	38,776.94	98.90	0.26%
NZX 50 Index	12,752.58	127.78	-0.99%
S&P 500	6,071.32	46.20	-0.76%
S&P/ASX 200	8,296.20	26.60	-0.32%
SSE Composite Index	3,379.11	28.33	0.85%